组织金属蛋白酶抑制剂 (TIMPs) 调节血小板ADAM10活动
Christine Shu Mei Lee1, Amandeep Kaur1, Samantha J Montague1
1Division of Genome Science and Cancer, John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
Platelets
|November 30, 2023
概括
组织金属蛋白酶抑制剂 (TIMPs) 调节血小板ADAM10活性,但在激活时不会强烈调节葡萄糖蛋白VI (GPVI) 的分泌. 这项研究为血小板受体调节提供了新的见解.
科学领域:
- 生物化学 生物化学
- 血液学 血液学 血液学
- 分子生物学分子生物学
背景情况:
- 血小板糖蛋白VI (GPVI) 通过金属蛋白酶活性从激活的血小板中排出.
- 甲分解蛋白和甲蛋白酶 (ADAM) 10是中介GPVI分离的主要酶.
- 组织金属蛋白酶抑制剂 (TIMPs) 在调节血小板ADAM活性和GPVI分泌中的作用尚不清楚.
研究的目的:
- 量化休息和激活血小板上的TIMP水平.
- 为了评估TIMPs对血小板ADAM10活动的影响.
- 为了确定TIMPs是否调节GPVI的依赖带的脱落.
主要方法:
- 流细胞计和多重ELISA被用于量化血小板上的TIMP水平.
- 用重组TIMP3来评估其对血小板ADAM10活性的影响.
- 使用ADAM10特异性抑制剂和EDTA来调节GPVI分泌.
主要成果:
- 所有的TIMP都在血小板上被检测到的水平有所变化;TIMP1和TIMP2在血中很丰富.
- 再组合的TIMP3显著抑制了静止和激活的血小板ADAM10活动.
- 再组合的TIMP2仅对联体启动的GPVI分泌产生了适度的抑制.
结论:
- 血小板TIMP可以调节血小板ADAM10活动.
- 没有TIMP强烈调节依赖带的GPVI脱落.
- 这些发现为调节血小板受体sheddase活性提供了新的见解.
相关概念视频
Formation of the Platelet Plug
6.4K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.4K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
532
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
532
Role of Matrix Metalloproteases in Degradation of ECM
2.4K
Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
2.4K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
711
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
711
Intracellular Signaling Affects Focal Adhesions
2.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.7K
Clot Retraction and Fibrinolysis
6.2K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.2K


